Researchers at UT Southwestern Medical Center have discovered sets of genes active in cancer cells and normal tissue that predict survival time and potential new treatments for patients with non-small cell lung cancer.
“Patient responses to cancer treatment vary widely and often depend on subtle biological differences among tumours,” said Dr David Mangelsdorf, chairman of pharmacology at UT Southwestern and co-lead author of the study, published 14 December by PLoS
No comments:
Post a Comment